Cost-Effectiveness Of Apixaban Compared To Warfarin And Aspirin In Patients With Non-Valvular Atrial Fibrillation (Nvaf) In The Russian Federation
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1441
https://www.valueinhealthjournal.com/article/S1098-3015(14)03371-3/fulltext
Title :
Cost-Effectiveness Of Apixaban Compared To Warfarin And Aspirin In Patients With Non-Valvular Atrial Fibrillation (Nvaf) In The Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03371-3&doi=10.1016/j.jval.2014.08.1441
First page :
A489
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
924